MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
790
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
26
Brand share
34.6%
Top prescribed drugs
Anastrozole129 claims
Rivaroxaban96 claims
Prednisone74 claims
Abiraterone Acetate60 claims
Hydroxyurea49 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Mohammad Fekrazad's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| ANTELOPE VALLEY HEALTH CARE DISTRICT | 106 | 1,419 |
| Nimit Sudan Hematology-Oncology · Encino, CA | 72 | 1,476 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 32 | 532 |
| Khalid Javeri Diagnostic Radiology · Santa Monica, CA | 30 | 129 |
| Viken Manjikian Diagnostic Radiology · Eden Prairie, MN | 24 | 107 |
| Yih-Dar Nien General Surgery · Encino, CA | 21 | 182 |
| LASK, DAVID | 15 | 60 |
| Vivaik Tyagi Gastroenterology · Lancaster, CA | 14 | 129 |
| RIDGECREST REGIONAL HOSPITAL | 12 | 175 |
| Olga Lyass Diagnostic Radiology · Lancaster, CA | 11 | 28 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE